State of Alaska Department of Revenue’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.3M | Buy |
11,478
+1,008
| +10% | +$115K | 0.01% | 913 |
|
2025
Q1 | $1.1M | Sell |
10,470
-269
| -3% | -$28.3K | 0.01% | 964 |
|
2024
Q4 | $1.15M | Buy |
10,739
+314
| +3% | +$33.6K | 0.01% | 984 |
|
2024
Q3 | $1.04M | Buy |
10,425
+510
| +5% | +$51K | 0.01% | 1044 |
|
2024
Q2 | $835K | Sell |
9,915
-70
| -0.7% | -$5.9K | 0.01% | 1103 |
|
2024
Q1 | $729K | Sell |
9,985
-99
| -1% | -$7.23K | 0.01% | 1206 |
|
2023
Q4 | $720K | Sell |
10,084
-74
| -0.7% | -$5.28K | 0.01% | 1180 |
|
2023
Q3 | $608K | Sell |
10,158
-639
| -6% | -$38.2K | 0.01% | 1225 |
|
2023
Q2 | $778K | Sell |
10,797
-193
| -2% | -$13.9K | 0.01% | 1118 |
|
2023
Q1 | $808K | Sell |
10,990
-185
| -2% | -$13.6K | 0.01% | 1093 |
|
2022
Q4 | $746K | Sell |
11,175
-6,626
| -37% | -$442K | 0.01% | 1139 |
|
2022
Q3 | $956K | Sell |
17,801
-2,642
| -13% | -$142K | 0.01% | 940 |
|
2022
Q2 | $1.14M | Buy |
20,443
+1,803
| +10% | +$100K | 0.01% | 885 |
|
2022
Q1 | $1.31M | Sell |
18,640
-328
| -2% | -$23K | 0.01% | 856 |
|
2021
Q4 | $1.83M | Sell |
18,968
-537
| -3% | -$51.7K | 0.02% | 757 |
|
2021
Q3 | $1.7M | Buy |
19,505
+15,360
| +371% | +$1.33M | 0.02% | 791 |
|
2021
Q2 | $339K | Sell |
4,145
-28
| -0.7% | -$2.29K | ﹤0.01% | 1560 |
|
2021
Q1 | $396K | Sell |
4,173
-16
| -0.4% | -$1.52K | ﹤0.01% | 1500 |
|
2020
Q4 | $259K | Sell |
4,189
-202
| -5% | -$12.5K | ﹤0.01% | 1557 |
|
2020
Q3 | $261K | Sell |
4,391
-184
| -4% | -$10.9K | ﹤0.01% | 1475 |
|
2020
Q2 | $319K | Buy |
4,575
+24
| +0.5% | +$1.67K | ﹤0.01% | 1422 |
|
2020
Q1 | $206K | Sell |
4,551
-77
| -2% | -$3.49K | ﹤0.01% | 1440 |
|
2019
Q4 | $301K | Sell |
4,628
-793
| -15% | -$51.6K | ﹤0.01% | 1486 |
|
2019
Q3 | $336K | Buy |
+5,421
| New | +$336K | ﹤0.01% | 1407 |
|
2018
Q4 | – | Sell |
-11,256
| Closed | -$1.93M | – | 1668 |
|
2018
Q3 | $1.93M | Buy |
11,256
+88
| +0.8% | +$15.1K | 0.03% | 545 |
|
2018
Q2 | $1.44M | Buy |
11,168
+256
| +2% | +$33.1K | 0.03% | 601 |
|
2018
Q1 | $1.12M | Buy |
10,912
+4,168
| +62% | +$429K | 0.02% | 648 |
|
2017
Q4 | $576K | Buy |
6,744
+112
| +2% | +$9.57K | 0.01% | 743 |
|
2017
Q3 | $563K | Buy |
6,632
+610
| +10% | +$51.8K | 0.03% | 665 |
|
2017
Q2 | $456K | Buy |
6,022
+2,656
| +79% | +$201K | 0.03% | 461 |
|
2017
Q1 | $222K | Buy |
3,366
+64
| +2% | +$4.22K | 0.02% | 626 |
|
2016
Q4 | $209K | Buy |
+3,302
| New | +$209K | 0.02% | 422 |
|